Evidence map›Paper›PMID 32228494›Full record

ArticleBMC nephrology2020

HLA-G14bp ins/del polymorphism and post-transplant weight gain in kidney transplantation: potential implications beyond tolerance.

Daniela Piancatelli, Daniela Maccarone, Alessia Colanardi, Pierluigi Sebastiani, Katia Clemente, Samuele Iesari, Quirino Lai, Francesco Pisani

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Daniela PiancatelliNational Research Council (CNR) - Institute of Translational Pharmacology (IFT), Via Carducci, 32, 67100, L'Aquila, Italy. daniela.piancatelli@cnr.it.
Daniela MaccaroneRegional Center for Organ Transplantation (CRT), S. Salvatore Hospital, L'Aquila, Italy.
Alessia ColanardiNational Research Council (CNR) - Institute of Translational Pharmacology (IFT), Via Carducci, 32, 67100, L'Aquila, Italy.
Pierluigi SebastianiNational Research Council (CNR) - Institute of Translational Pharmacology (IFT), Via Carducci, 32, 67100, L'Aquila, Italy.
Katia ClementeGeneral Surgery and Organ Transplantation, S. Salvatore Hospital, L'Aquila, Italy.
Samuele IesariPôle de chirurgie expérimentale et transplantation, Institut de recherche expérimentale et clinique, Université catholique de Louvain, Brussels, Belgium.
Quirino LaiTransplant Unit, University "La Sapienza", Rome, Italy.
Francesco PisaniGeneral Surgery and Organ Transplantation, S. Salvatore Hospital, L'Aquila, Italy.
National Research Council · ITSan Salvatore Hospital · ITUniversity of L'Aquila · ITIstituto di Farmacologia Traslazionale · ITSapienza University of Rome · IT

Funding

Consiglio Nazionale delle Ricerche not applicable
6 · The paper itself

Abstract

backgroundHuman leukocyte antigen (HLA)-G is a non-classical HLA molecule with immunomodulant and immunosuppressive functions, involved in transplantation tolerance. HLA-G14bp ins/del polymorphism in exon 8 has been associated with allograft rejection and kidney transplant outcome, with controversial results. We investigated associations of HLA-G14bp ins/del polymorphism on onset of some of the main post-transplant risk factors, like excess body weight, lipid abnormalities, increased fasting plasma glucose. Polymorphisms of cytokines with both immunosuppressive and metabolic effects were also assessed for comparisons and associated analysis.

methodsThe present study involved kidney transplant recipients (n = 173) in which body mass index, cholesterol, triglycerides, fasting plasma glucose were registered in the first years after transplantation and analyzed in association with genotypes. Presence of hypertension and smoking habits, demographic, transplant-related and therapeutic data of patients were also recorded. Polymerase chain reaction, sequence-specific primer amplification and Taqman allelic discrimination techniques were used for genotyping of HLA-G14bp ins/del, interleukin (IL)-10(-1082G > A,-819 T > C,-592A > C), transforming growth factor-β(+ 869 T > C,+915C > G), IL-6(-174G > C), tumor necrosis factor-α(-308G > A) and IL-18(-137G > C,-607C > A). Effects of genotypes on clinical markers at each time point (pre-transplant and 1 to 5 years after transplant) were analyzed using a repeated-measures general linear model analysis; adjustment for potential confounders was performed.

resultsResults showed that HLA-G14bp ins/ins was significantly associated with obesity, in particular after transplantation (3 years, p = 0.002, OR = 4.48, 95% CI:1.76-11.41). Post-transplant body mass index was significantly increased in HLA-G14bp ins/ins carriers (3 and 4 years, p = 0.033 and p = 0.044); effects of HLA-G14bp genotypes on post-transplant BMI were confirmed by using repeated-measures analysis and after controlling for confounding variables. Cytokine genotypes did not associate with the examined factors.

conclusionsThe study of transplanted patients allowed to evidence a potential relationship between post-transplant weight gain and HLA-G14bp ins/del polymorphism, previously involved in rejection for its immunosuppressive/tolerogenic activity. This novel association could widen the knowledge of the role and functions of HLA-G molecules in diseases and transplantation.

Indexed as

CytokinesGraft RejectionHLA-G AntigensObesityPostoperative ComplicationsWeight GainBody Mass IndexFemaleGenetic Predisposition to DiseaseHumansImmune ToleranceImmunologic FactorsKidney TransplantationMaleMiddle AgedPolymorphism, GeneticCytokinesHLA-G AntigensImmunologic FactorsGene polymorphismHLA-GImmunogeneticsKidney transplantObesity

Identifiers

PMID32228494
PMCPMC7104538
OpenAlexW3013742390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.